Trials / Completed
CompletedNCT02608502
A Study to Evaluate the Efficacy of an RSV F Vaccine in Older Adults
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 11,850 (actual)
- Sponsor
- Novavax · Industry
- Sex
- All
- Age
- 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to demonstrate the efficacy of the RSV F vaccine at a dose of 135µg via intramuscular (IM) injection in the prevention of moderate-severe RSV-associated lower respiratory tract disease (RSV-LRTD) in older adults ≥ 60 years of age.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | RSV-F Vaccine | |
| BIOLOGICAL | Phosphate Buffer Placebo |
Timeline
- Start date
- 2015-11-01
- Primary completion
- 2016-12-01
- Completion
- 2016-12-01
- First posted
- 2015-11-18
- Last updated
- 2022-07-19
Locations
60 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02608502. Inclusion in this directory is not an endorsement.